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INTRODUCTION
Self-harm, defined as intentional self-injury or intentional drug overdoses irrespective of level of suicidal intent or type or degree of motivation (Hawton et al., 2003; NICE, 2011) . It is a growing problem in many countries worldwide. In England alone, for example, there are now more than 200,000 emergency department presentations for self-harm each year (Hawton et al., 2007) . Self-harm is also frequently repeated. Up to one-quarter of patients who present to hospital following an episode of self-harm will return to the same hospital within one year following a repeat episode Owens et al., 2002) . Self-harm is also a significant risk factor for death by suicide .
Given the prevalence of self-harm, the frequency with which it is repeated, and its association with suicide, it is important that effective interventions are developed and rigorously evaluated for their effectiveness (Hawton et al., 2016a) .
Guidelines for the evaluation of complex multicomponent interventions, such as those typically developed for the prevention of self-harm, emphasize the primacy of the randomized controlled trial (RCTs) design as the randomization process can protect against selection bias and other threats to internal validity (Craig et al., 2008) . RCTs of psychological interventions for self-harm typically compare the active treatment condition against "treatment as usual" (TAU). However, within psychiatry trials the TAU condition is typically poorly defined (Burns, 2009) , despite calls since 1996 to define the components of the TAU condition as precisely as the active intervention condition (Burns and Priebe, 1996) .
Complicating matters is the fact that TAU necessarily varies between studies as a result of service-related differences over time. It has been demonstrated, for example, that the apparent effectiveness of assertive community treatment (ACT) has A C C E P T E D M A N U S C R I P T 6 diminished over time as many of the key features of ACT, particularly with respect to reduced case load and increased service intensity, have come to be integrated into routine community care (Clarke et al., 2000) . TAU will also vary between different locations, and especially between different countries. TAU practices can also vary between centres in the case of multicentre trials (Saunders and Smith, 2016) , and yet, these differences have generally been ignored in self-harm trials.
Variability in the TAU condition can seriously affect the magnitude of the effect size for the experimental intervention in RCTs of psychosocial interventions.
For example, it has been shown that whilst manualized interventions for anxiety and depression (e.g., cognitive behavioural therapy [CBT] ) are associated with significant benefits in terms of reduced symptomatology when compared to TAU, this effect is attenuated when limited to RCTs in which TAU contained some component of the active treatment (Wampold et al., 2011) . Similar effects have been observed in psychosocial trials for cannabis cessation (Cooper et al., 2015) . Effect size attenuation may be particularly likely in RCTs conducted in recent years as CBT has become a standard therapeutic approach included in the training of mental health professionals (Sarin et al., 2011) .
Despite these important findings the nature of TAU is rarely investigated as an important source of heterogeneity in meta-analyses of the effectiveness of psychosocial treatments (Van de Wiel et al., 2007; Watts et al., 2015) . For this reason, we have investigated the quality of reporting for the control condition in trials of CBT-based therapies for self-harm to highlight the potential impact of the TAU condition on the magnitude of the reported treatment effect for these interventions and to provide guidance on reporting of TAU for future trialists in this area (Watts et al., 2015) . This work extends our recent update of the treatment literature on the A C C E P T E D M A N U S C R I P T 7 effectiveness of psychosocial interventions for self-harm in adults (Hawton et al., 2016a, b) , in which we conclude that there is now evidence to support the use of brief (i.e., up to 10 sessions) CBT-based psychotherapy for reducing the proportion of adults who engage in further self-harm and for having other benefits for the emotional well-being of patients.
METHOD

Electronic Search Strategy
We searched for RCTs of psychosocial treatments in adults following a recent (within six months) episode of self-harm indexed in five electronic databases (CCDANCTR-Studies and References, CENTRAL, MEDLINE, EMBASE, and PsycINFO) between 1 January, 1998 and 29 April, 2015 using the electronic search strategy outlined in Supplementary Document SD1. The reference lists of 44 major review papers as well as ten English language specialist suicidology journals were also manually searched and researchers active in the field were contacted to identify unpublished literature inadvertently missed by the electronic search.
Trial Eligibility
RCTs were eligible for inclusion provided they met the following criteria: (1) used random allocation to assign participants to the intervention and control groups;
(2) participants were 18 years or older at the point of randomization; (3) all participants had engaged in self-harm (defined as any non-fatal act of self-injury and/or intentional drug overdose irrespective of the extent of suicidal intent or any other type of motivation; Hawton et al., 2003) no more than six months prior to randomization; and (4) the trial evaluated the effectiveness of a CBT-based therapy,
including cognitive behavioural therapy (CBT), problem-solving therapy (PST), or a combination of these, relative to treatment as usual (TAU). Non-English language studies were eligible for inclusion in this review and were translated by native speakers.
Trials were independently screened for inclusion by KW and one of TTS, EA, DG, PH, ET, or KvH. Disagreements were resolved following discussion with KH.
Where insufficient information was recorded in the study report to determine eligibility, study authors were contacted to provide additional clarification.
Data Extraction
Outcome data
For quantitative analyses, the primary outcome measure was repetition of selfharm at the six month, twelve month, and final follow-up assessment points.
Secondary outcomes included scores for depression, hopelessness, and suicidal ideation at the final follow-up assessment. Quantitative data relating to these outcomes were extracted independently by KW and one of TTS, EA, DG, PH, ET, or KvH. Again disagreements were resolved following discussion with KH. Study authors were contacted to provide additional information where data were either missing or unclear.
To investigate homogeneity of the effect size estimate between studies, we calculated the I 2 statistic, which indicates the percentage of variability in effect sizes between studies resulting from genuine methodological and other differences, rather than chance alone. This statistic can take any value between 0% and 100%, with values greater than 75% conventionally interpreted as indicating substantial levels of between-study variability (Higgins et al., 2003) .
Information on the content of the TAU condition was assessed independently by KW and DPDM using a standard pro forma. Details extracted included definition of the TAU condition and whether any component/s of the active treatment condition was/were available to participants randomized to the TAU condition. Disagreements were resolved following discussion with KH.
TAU was classified as either: (1) multidisciplinary treatment (i.e., comprising both psychological and pharmacological treatment from a range of psychiatric, personality, addictions, and/or other services according to need); (2) psychotherapy only; (3) pharmacotherapy only; (4) treatment by GP/primary care physician only; (5) minimal contact (i.e., psychoeducation, bibliotherapy, or remote contact only); or (6) unclear/not adequately described (Watts et al., 2015) .
Risk of Bias Assessment
We also assessed risk of bias for each included trial using the approach favoured by the Cochrane Collaboration (Higgins et al., 2008b) . Specifically, each study was rated as at high, unclear, or low risk of bias with respect to the following domains: adequacy of the random sequence generation procedure, adequacy of allocation concealment, and presence of participant and clinical personnel blinding, outcome assessor blinding, incomplete outcome data, selective outcome reporting, and any other bias. We also recorded information on the proportion of participants for whom data on the primary outcome, repetition of self-harm, was lacking at the final follow-up assessment.
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10 For the incomplete outcome data criterion, we rated trials as high risk of bias where there were ≥10% missing data for the primary outcome and data had been analysed according to per protocol principles, and where no method had been used to statistically account for missing data. There was one exception to this. Where the last observation carried forward (LOC) method had been used to account for missing data, we rated these trials as unclear risk of bias for this criterion as the LOC method has been shown to introduce bias (Engles and Diehr, 2003) .
Statistical Analyses
Proportions of patients repeating self-harm at the six month, 12 month, and last available follow-up assessment were summarized using the odds ratio (OR) and the accompanying 95% confidence interval (CI). Data for all continuous secondary outcome measures, including depression, hopelessness, and suicidal ideation scores, were assessed using the standard mean difference (SMD) and 95% CI, as recommended by the Cochrane Collaboration (Higgins et al., 2008a) , because the studies included in the meta-analysis used a variety of different psychometric measures to assess these outcomes.
Given that departure from the intention-to-treat principle, in which all participants are analysed in the groups to which they had been randomly allocated (Hollis, 1999) , is associated with artificial inflation of the effect size estimate in treatment intervention trials (Abraha et al., 2015) , where possible we analysed data according to the ITT principle. This approach was not always possible, however, particularly in cases where the outcome relied on patient self-reported data (e.g., depression, hopelessness, and suicidal ideation scores). In these cases we have therefore analysed all available case data. To account for any bias introduced by the
use of these data we have considered the effect of missing data for these outcomes within the text of the review, as recommended by the Cochrane Collaboration (Higgins et al., 2011) .
All analyses were undertaken in RevMan for Windows, version 5.3, using the Mantel-Haenszel random effects model for all dichotomous outcomes, and for continuous outcomes, using the inverted variance random effects model. Sub-group analyses to investigate whether the effectiveness of CBT-based interventions would vary as a result of the TAU condition were conducted using the random effects model.
RESULTS
The systematic search outlined in Supplementary Document SD1 retrieved a total of 23,830 citations. An additional 10 trials ongoing at the time of the systematic search were identified through correspondence with researchers in the field.
Following de-duplication, the overall figure was reduced to 16,799. A total of 16,538 were excluded following screening, whilst a further 237 were excluded after reviewing the full text. Seven trials were additionally excluded from the present review as they evaluated the effectiveness of a pharmacological intervention, whilst a further 11 trials were excluded as they evaluated an intervention for children and adolescents.
A further 37 trials were excluded from this version of the review as they evaluated a psychosocial intervention other than CBT-based psychotherapy. A total of 18 non-overlapping RCTs comparing CBT-based psychotherapy to TAU were therefore included in this study (Brown et al., 2005; Davidson et al., 2014; Dubois et al., 1999; Evans et al., 1999; Gibbons et al., 1978; Guthrie et al., 2001; Hatcher et al., 2011; Hawton et al., 1987; Husain et al., 2014; McAuliffe et al., 2014; Patsiokas and ACCEPTED MANUSCRIPT , 1985; Salkovskis et al., 1990; Slee et al., 2008; Stewart et al., 2009; Tapolaa et al., 2010; Tyrer et al., 2003; Wei et al., 2013; Weinberg et al., 2006) (Figure 1 ).
Study Characteristics
The included trials comprised a total of 2,433 participants. Of the 13 trials that recorded information on age, the weighted average age at randomization was 29.6 (SD 8.3; range 15.0 to 66.0) years. Of the 16 trials that recorded information on gender, 62.5% (n=1,833) of participants were female. All participants had engaged in at least one episode of SH in the six months prior to randomization. Further characteristics of these 18 studies can be found in Table 1 .
The majority of these 18 trials were conducted in the United Kingdom (N=7; (Davidson et al., 2014; Evans et al., 1999; Gibbons et al., 1978; Guthrie et al., 2001; Hawton et al., 1987; Salkovskis et al., 1990; Tyrer et al., 2003) followed by the United States of America (N=3; (Brown et al., 2005; Patsiokas and Clum, 1985; Weinberg et al., 2006) with one trial each from Australia (Stewart et al., 2009 ), China (Wei et al., 2013) , Finland (Tapolaa et al., 2010) , France (Dubois et al., 1999) , The Netherlands (Slee et al., 2008) , New Zealand (Hatcher et al., 2011) , Pakistan (Husain et al., 2014) , and the Republic of Ireland (McAuliffe et al., 2014) .
Methodological Quality
The included trials had high risk of bias. All trials were rated as at high risk of bias with respect to participant and clinical personnel blinding and at unclear risk of bias for selective outcome reporting (Table 2) . Additionally, trial protocols were generally not available as many of the trials included in this review had been Four further trials (22.2%) were rated as at high risk of bias for outcome assessor blinding. In two cases this was because all outcomes relied on self-reported measures and participants themselves were not blind to treatment allocation (Guthrie et al., 2001; Slee et al., 2008) , whilst in the remaining two cases, outcome assessor blinding could not be achieved due to feasibility limitations (Brown et al., 2005; Stewart et al., 2009 ). Performance and detection bias therefore cannot be ruled out for the majority of the trials included in this review.
One study (5.6%) was rated as at high risk of bias for allocation concealment as this study made use of Zelen"s post-randomization consent procedure in which participants are asked to consent to inclusion in the trial after being notified to which group, intervention or TAU, they were allocated (Hatcher et al., 2011) . Selection bias therefore cannot be ruled out.
In nine trials there were either no withdrawals from the study (Davidson et al., 2014; Gibbons et al., 1978; Guthrie et al., 2001; Hawton et al., 1987; Salkovskis et al., 1990; Weinberg et al., 2006) , or, less than 10% of the participant pool could not be located at follow-up (Evans et al., 1999; Husain et al., 2014; Slee et al., 2008) . In two trials (11.1%) either no information was provided on the amount of missing data at follow-up (Patsiokas and Clum, 1985) , or, no apparent attempt was made to follow-up patients post-intervention (Stewart et al., 2009 ). In three further trials, although greater than 10% of the participant pool could not be located at the final follow-up assessment, nonetheless, appropriate measures were used to account for missing data (Brown et al., 2005; Hatcher et al., 2011; Wei et al., 2013) . For the remaining four trials (38.9%), greater than 10% of the allocated participants could not be located at M A N U S C R I P T 14 the final follow-up assessment and no apparent attempt was made to statistically account for missing data (Dubois et al., 1999; McAuliffe et al., 2014; Tapolaa et al., 2010; Tyrer et al., 2003) . Missing data were a greater concern for the TAU arm as compared to the intervention arm (weighted average 12.4% versus 8.4%).
Description of Treatment As Usual
The content of TAU for each of the studies is summarized in Table 3 . In most studies a description of the TAU control condition was provided a priori (83.3%). For the majority of these trials TAU was multidisciplinary in nature, combining psychotherapy, pharmacotherapy, and referral to specialist services (e.g., personality disorder, addictions, and other services) as required (Davidson et al., 2014; Dubois et al., 1999; Evans et al., 1999; Gibbons et al., 1978; Guthrie et al., 2001; Hatcher et al., 2011; McAuliffe et al., 2014; Patsiokas and Clum, 1985; Slee et al., 2008; Stewart et al., 2009; Tapolaa et al., 2010; Tyrer et al., 2003; Weinberg et al., 2006) . For two further trials TAU comprised referral to the participant"s primary care physician (Hawton et al., 1987; Husain et al., 2014) .
In two trials (11.1%), however, there was no description of the TAU condition (Salkovskis et al., 1990; Wei et al., 2013) . In one further trial (5.6%) insufficient details of TAU content were provided (Brown et al., 2005) . In line with previous work (Watts et al., 2015) , we therefore categorized the TAU condition in these three trials as unclear.
Effect of Treatment As Usual Condition on Repetition of Self-Harm
As we have previously reported (Hawton et al., 2016a, b) , CBT-based psychotherapy was associated with a significant reduction in the proportion of people repeating self-harm at the final follow-up assessment in these trials (OR 0.70, 95% CI 0.55 to 0.88; p=0.003; Figure 2 ). However, sub-group analyses demonstrated that the TAU condition was significantly associated with variability in the finding regarding the effectiveness of CBT-based psychotherapy (χ 2 =6.38, df=2, p=0.04, I 2 =68.6%; Figure 2 ). Specifically, whilst CBT-based psychotherapy was strongly associated with a significant treatment effect for repetition of self-harm when compared to an unclear TAU condition (OR 0.29, 95% CI 0.13 to 0.62; 3 trials), the effect size was reduced when compared to multidisciplinary TAU (OR 0.79, 95% CI 0.63 to 0.97; 12 trials).
CBT-based psychotherapy was not associated with a treatment effect for repetition of self-harm at this assessment point when compared to GP management (OR 053, 95% CI 0.15 to 1.93; two trials; Figure 2 ). However, it is important to note that only two trials were included in this latter sub-group and therefore the estimate of effect for this finding is imprecise.
Effect of Treatment As Usual Condition on Suicidal Ideation Scores
CBT-based psychotherapy was associated with a significant treatment effect for suicidal ideation scores at the final assessment point (SMD -0.28, 95% CI -0.47 to -0.09; p=0.003; Figure 3 ). There was no evidence of a significant difference in the effect size as a result of the TAU comparator condition used (χ 2 =0.05, df=1, p=0.83; I 2 =0%; Figure 3 ).
Effect of Treatment As Usual Condition on Depression Scores
CBT-based psychotherapy was associated with a significant treatment effect for depression scores at the final follow-up assessment (SMD -0.31, 95% CI -0.48 to -0.14; p=0.0003; Figure 4) . Although the effect for CBT-based psychotherapy on M A N U S C R I P T 16 depression scores was strongest when compared against multidisciplinary TAU (SMD -0.35, 95% CI -0.58 to -0.12; 9 trials), followed by GP management (SMD -0.28, 95% CI -0.52 to -0.04; 2 trials), and non-significantly associated with a treatment effect for depression scores when compared to unclear TAU (SMD -0.33, 95% CI -0.94 to 0.28; 3 trials), these sub-group differences were not significant (χ 2 =0.18, df=2, p=0.91, I 2 =0%; Figure 4 ).
Effect of Treatment As Usual Condition on Hopelessness Scores
CBT-based psychotherapy was associated with a significant reduction in hopelessness scores at the final follow-up assessment (SMD -0.31, 95% CI -0.51 to -0.10; p=0.003; Figure 5 ). Although this effect appeared to be strongest when CBTbased psychotherapy was compared to an unclear TAU condition (SMD -0.68, 95%
CI -1.80 to 0.43; 2 trials), in contrast to where TAU comprised either GP management (SMD -0.41, 95% CI -0.68 to -0.14; 1 trial) or multidisciplinary TAU (SMD -0.22, 95% CI -0.45 to 0.01; 4 trials), these subgroup differences were not significant (χ 2 =1.61, df=2, p=0.45, I 2 =0%; Figure 5 ).
DISCUSSION
We have previously shown that CBT-based psychotherapy is associated with significant post-treatment reductions in self-harm, depression, hopelessness, and suicidal ideation, but not suicide (although the number of events for this outcome was relatively small) (Hawton et al., 2016a, b) . However, differences in the quality of the TAU comparator condition between trials still represents an important source of variability (Arensman et al., 2001) . The aim of the present review, therefore, was to M A N U S C R I P T 17 highlight the potential impact of the TAU condition on estimates of treatment effects for these interventions and to provide reporting guidance for future trials in this area.
In few trials were details provided of the treatment components offered to participants allocated to the TAU condition. In fewer still was the number of treatment sessions attended by control participants reported. Additionally, and particularly importantly, no author provided a detailed break-down of the treatments actually received by participants in the TAU condition. This is in contrast to a recent report on an RCT of dialectical behaviour therapy for self-harm in adults which includes a supplementary table outlining the various treatments received by participants allocated to the TAU condition and the mean number of months the participants received each of these components (Priebe et al., 2012) . We recommend that in future trials of psychosocial interventions for self-harm in which TAU is the control condition researchers should, where possible, aim to reproduce such tables to assist in calculating treatment dosage for participants allocated to the TAU arm.
Recommendations for TAU Treatment Conditions
Although in most trials included in this review some description of the content of the TAU condition was provided (83.3%), sub-group analyses suggested evidence of a significant difference in effectiveness for CBT-based psychotherapy for the primary outcome measure, repetition of self-harm, for those studies in which TAU content was not adequately described. However, it should be noted that, generally, for those trials in which TAU content was not clearly described they were also rated as being or poor quality in other aspects of trial design. Thus, we cannot we clear if this finding is specific to description of TAU content, or a more global consequence of trial design. Also, given that components of CBT-based psychotherapy may have
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18 come to be integrated into TAU across a number of services internationally, this finding may also be partly explained by potential similarities between the CBT-based psychotherapy treatment condition and the TAU condition. However, this cannot be verified at the present time due to limited information on TAU content in many of the included studies.
For the secondary outcome measure of depression scores, in contrast, we found a non-significant trend towards stronger effects for CBT-based psychotherapy when compared to multidisciplinary TAU as compared to when TAU content was not adequately described. However, the effect for hopelessness scores was consistent with that observed for repetition of self-harm. As no studies that reported outcome data for suicidal ideation scores were rated as unclear TAU, we were unable to investigate the impact of an unclear TAU condition on the magnitude of the effect size for this outcome.
In none of the included trials were there clear descriptions of the treatment components (e.g., psychotherapy, pharmacotherapy, welfare) available to participants assigned to the TAU condition and the number of participants that received each of these. We suggest that in future trials researchers should where possible provide details on the type(s) of treatments available to participants assigned to the TAU group, the number of patients in the TAU condition who received each component ( received, however, will help to determine whether the TAU condition reflects current clinical best-practice for the treatment setting, and whether the TAU condition controlled for any non-specific effect(s) of the intervention condition.
For one trial in which the intervention treatment was offered in a group-based format, TAU involved referral for predominately individual-based psychotherapy (McAuliffe et al., 2014) . Offering psychotherapy in a group-based environment may provide a number of additional beneficial effects beyond the hypothesized mechanism of change for this intervention, such as helping participants overcome social isolation.
Alternatively, offering treatment in a group-based format may be detrimental for this patient group, given findings from one Australian trial of group-based CBT with adolescent self-harm patients in which information shared during a group-based psychotherapy session was posted on a participant"s personal web-blog (Hazell et al., 2009 ). There may also be more detrimental effects of group-based CBT when selfharm patients with a history of frequent self-harm repetition are involved, as they may be particularly vulnerable to the social contagion effects of self-harm (Haw et al., 2013) .
Strengths and Limitations
The primary strength of this review relates to the systematic approach used to identify and include data from all relevant trials and the extent to which most of them include detailed information on content of therapy and outcomes. In all trials there were far more details of the experimental treatment compared to TAU. The included trials all had risk of bias in that they were rated as at high risk of bias with respect to participant and clinical personnel blinding and at unclear risk of bias for selective outcome reporting. In part, however, this reflects the fact that the trials included in A C C E P T E D M A N U S C R I P T 20 this review examined the effectiveness of psychotherapy and it is generally not possible to blind either the participants themselves, or the therapists delivering treatment, to psychological therapy. There was also considerable variability in the proportion of participants for whom follow-up information on the primary outcome measure, repetition of self-harm, was lacking, ranging from 0% for six studies to over half (63.2%) for one study. In the main this likely reflects differences in the approach used to ascertain repetition. For those studies in which repetition of self-harm was ascertained from medical and/or hospital records, rates of missing data were lower than in those in which self-reported information was used as these data would only have been available for those able to be located at follow-up and may additionally have been affected by recall and other biases.
Conclusions
The present review suggests that whilst, overall, CBT-based psychotherapy was more effective than TAU in reducing the proportion of participants who self-harm and also depression, hopelessness and suicidal ideation at final follow-up, results varied by TAU content. Specifically, effects in favour of CBT-based psychotherapy in reducing repetition of self-harm were strongest where the TAU was not clearly described. The study shows that TAU content and quality is a significant, but infrequently investigated, source of heterogeneity between trials of interventions for the prevention of self-harm and, furthermore, that TAU is not a homogenous comparator. We suggest that in future, researchers in this field should carefully Table 3 . Treatment as usual (TAU) definition and classification for the 18 studies included in this review.
Study TAU Content and Quality Description TAU Classification
Brown et al., 2005
"Participants in both study groups received usual care from clinicians in the community as well as tracking and referral services…" (p.565). Unclear/Not Described
Davidson et al., 2014
"Treatment as usual (TAU) was referral to a community mental health team and included appointments from a psychiatrist and community psychiatric nurse. In-patient treatment was given when required" (p.109). 
Multiple Providers
Dubois
